Novel methods for the encapsulation of meglumine antimoniate into liposomes
Authors:
Open Access
- 1 July 2000
- journal article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 33 (7) , 841-846
Abstract
The antimonial drug, meglumine antimoniate, was successfully encapsulated in dehydration-rehydration vesicles and in freeze-dried empty liposomes (FDELs). High encapsulation efficiencies (from 28 to 58%) and low weight ratios of lipids to encapsulated antimony (from 1:0.15 to 1:0.3) were achieved. These formulations, contrary to those obtained by conventional methods, can be stored as intermediate lyophilized forms and reconstituted just before use. The efficacy of FDEL-encapsulated meglumine antimoniate was evaluated in hamsters experimentally infected with Leishmania chagasi. A significant reduction of liver parasite burdens was observed in animals treated with this preparation, when compared to control animals treated with empty liposomes. In contrast, free meglumine antimoniate was found to be inefficient when administered at a comparable dose of antimony. This novel liposome-based meglumine antimoniate formulation appears to be promising as a pharmaceutical product for the treatment of visceral leishmaniasis.Keywords
This publication has 10 references indexed in Scilit:
- Characterization of the Antimonial Antileishmanial Agent Meglumine Antimonate (Glucantime)Antimicrobial Agents and Chemotherapy, 1998
- Liposomes: quo vadis?Pharmaceutical Science & Technology Today, 1998
- Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 YearsClinical Infectious Diseases, 1997
- BIOPHARMACEUTICAL EVALUATION OF THE LIPOSOMES PREPARED BY REHYDRATION OF FREEZE-DRIED EMPTY LIPOSOMES (FDELs) WITH AN AQUEOUS SOLUTION OF A DRUGBiopharmaceutics & Drug Disposition, 1996
- Visceral Leishmaniasis in the BALB/c Mouse: A Comparison of thein VivoActivity of Five Non-Ionic Surfactant Vesicle Preparations of Sodium StibogluconateJournal of Drug Targeting, 1995
- Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconateJournal of Pharmacy and Pharmacology, 1986
- Liposomes as drug carriers in leishmaniasis and malariaParasitology Today, 1986
- Dehydration-Rehydration Vesicles: A Simple Method for High Yield Drug Entrapment in LiposomesNature Biotechnology, 1984
- Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomesJournal of Antimicrobial Chemotherapy, 1981
- Liposomes in leishmaniasis: Therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracyclineLife Sciences, 1980